Ashurst advises on £703.1 million recommended takeover of Ergomed by Permira Advisers

Global law firm Ashurst is advising Rothschild & Co on the approximately £703.1 million recommended cash offer for AIM listed company Ergomed plc (Ergomed) by Eden AcquisitionCo Limited, a newly incorporated entity formed by funds advised by Permira Advisers LLP (Permira).

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval PV and medical information. Ergomed's fast-growing services business includes an industry-leading suite of specialist PV solutions, integrated under the PrimeVigilance brand, a full range of high-quality clinical research and trial management services under the Ergomed brand and mission-critical regualtory compliance and consulting services under the ADAMAS brand.

The Ashurst team was led by partnersTom Mercer,Harry ThimontandTim Rennie, assisted by senior associates Maria McAlister and Aimee Carroll-Hewitt and associates Sandile Sibiya, Millie Gibbs, Gareth Mair and Roshni Mehra.